Published in

Frontiers Media, Frontiers in Cardiovascular Medicine, (9), 2022

DOI: 10.3389/fcvm.2022.964324

Links

Tools

Export citation

Search in Google Scholar

Successful immune checkpoint inhibitor rechallenge after immune-related pericarditis: Clinical case series

Journal article published in 2022 by Adrian M. Chye, Ina I. C. Nordman, Aaron L. Sverdlov ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

Pericardial diseases secondary to immune checkpoint inhibitors (ICI) are rare. Here, we describe two cases of immune-related pericarditis caused by ICI for treatment of advanced NSCLC. Select patients can be successfully rechallenged with ICI after immune-related pericardial disease.